Given the importance of intestinal ACE2 in regulating inflammation and glucose transport [15,16,41], we hypothesised that changes in ACE2 and TMPRSS2 due to low-grade inflammation and hyperglycaemia potentially contribute to severe disease development in COVID-19 patients with diabetes. Here, ACE2 is linked to Hyperglycemia.